Dechra Veterinary Products Inc. has recalled 24 cartons of Clavacillin (amoxicillin trihydrate/clavulanate potassium) Veterinary Tablets used for dogs. The recall was initiated because the tablets failed potency testing for clavulanic acid during stability checks at the 9-month mark, meaning the medication may not be as effective as intended. No incidents or injuries related to this recall have been reported.
Reduced potency in an antibiotic can lead to ineffective treatment of bacterial infections in dogs, potentially allowing the infection to persist or worsen. Because the clavulanic acid levels are lower than required, the medication may fail to provide the necessary therapeutic benefit to the animal.
You have 2 options:
ANADA 200-592; Each carton contains 15 strips of 14 tablets each.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response